Altamira Therapeutics is a leading brand dedicated to developing RNA-based therapeutics for extrahepatic targets. With a focus on targeting unmet medical needs, they offer innovative solutions in the field of RNA therapeutics, allergy and viral infections, and inner ear disorders. Their team consists of a knowledgeable Leadership Team and Board of Directors who strive to push the boundaries of medical research and development.

Altamira Therapeutics also has legacy programs in allergy and viral infections, and inner ear disorders, which they are actively looking to partner with. Their commitment to exclusively focusing on the exciting opportunities in RNA means that they are at the forefront of cutting-edge research and advancements in the field. With a dedication to improving the lives of patients and a strong portfolio of programs, Altamira Therapeutics is a trusted brand that consistently delivers ground-breaking solutions.

Stay up to date with the latest news and advancements from Altamira Therapeutics to learn more about their groundbreaking work in RNA therapies